local_hospital

Debreceni Egyetem Klinikai Központ, Belgyógyászati Klinika A épület

Address
Nagyerdei körút 98, Debrecen, Hungary

Debreceni Egyetem Klinikai Központ - Internal Medicine Clinical Research

The Internal Medicine Clinic (Building A) at Debreceni Egyetem Klinikai Központ serves as a distinguished clinical research center conducting specialized investigations across diverse therapeutic areas. The center demonstrates particular expertise in rare endocrine disorders and infectious disease management, contributing to the advancement of novel therapeutic interventions for complex medical conditions.

  • Endocrine disorders research, with focus on Cushing's Disease and cortisol regulation pathways
  • Pediatric infectious diseases including complicated urinary tract infections and acute pyelonephritis
  • Pharmacokinetic studies evaluating drug absorption, distribution, and metabolism across different patient populations

The facility's research portfolio encompasses comprehensive safety and tolerability assessments for investigational medications, ranging from hormonal regulation therapies to advanced antibiotic combinations. The center's capabilities extend across the full age spectrum, conducting studies in both adult populations with rare diseases and pediatric patients from birth through adolescence, demonstrating versatility in clinical trial execution and patient care.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 332 other sites in Hungary

description
Trial volume
2
Outperforms 37% of sites
public
Therapeutic diversity
2areas
Outperforms 50% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — Hungary

Select a therapeutic area to compare against other sites in Hungary.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Hungary

Market Share

Country: Hungary

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Debreceni Egyetem Klinikai Központ, Belgyógyászati Klinika A épület

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Phase 2 Study on Pharmacokinetics, Safety, and Tolerability of Cefepime-Enmetazobactam in Pediatric Patients with Complicated Urinary Tract InfectionsOrchid Pharma Europe GmbHPhase IINot Yet RecruitingJan 2023

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Ag139091Unknown2024-09-262024-09-26

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.